Position in INAB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$248,351
-$344,644 QoQ
Shares Held
167,805
-33.8% QoQ
Ownership
1.70%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#5
of 19 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in INAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BIOS Capital Management, LP holds $52,866,301 across 6 Biotechnology names. INAB ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACTU |
Actuate Therapeutics, Inc.
|
10,049,996 | $27,536,988 | |
| 2 | IRD |
Opus Genetics, Inc.
|
3,683,429 | $16,759,601 | |
| 3 | CGTX |
Cognition Therapeutics Inc
|
6,000,000 | $4,559,999 | |
| 4 | RNTX |
Rein Therapeutics, Inc.
|
1,982,375 | $2,577,087 | |
| 5 | LTRN |
Lantern Pharma Inc.
|
864,435 | $1,184,275 | |
| 6 | INAB |
In8bio, Inc.
This page
|
167,805 | $248,351 |
All Filings in INAB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $248,351 | 167,805 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $592,995 | 253,417 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||